Abstract
The Full Value of Improved Seasonal Influenza Vaccines Assessment (FVIVA) report outlines key considerations for advancing seasonal influenza vaccine development and describes the potential impact that improved vaccines can have on global public health. The report assesses the need for, and articulates the value of, more effective and durable seasonal influenza vaccines to address the significant global burden of seasonal influenza. Its findings can help to inform efforts to accelerate the development and availability of improved seasonal and pandemic influenza vaccines.
WHO
Influenza
